Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiopathic Parkinson's Disease
Clinical trial NCT04506073 · COMPLETED
Trial details
- NCT number
- NCT04506073
- Sponsor
- The University of Texas Health Science Center, Houston
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-09
- Primary completion
- 2023-07-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.